Oncotarget is a medical research journal that was founded in 2010. The peer reviewed journal focuses primarily on all aspects of oncology, but due to its success over the years, it plans to explore other disciplines of scientific research. Led by its chief editor Mikhail Blagosklonny, the journal is highly praised by most in the medical field circles for its insightful well-researched weekly publications. To increase the impact their research has in the scientific world; Oncology recently announced it would have two publications each week. The move has come up due to demand from its readers as it has improved the lives of many in the close to a decade period of its existence.
In its pursuit of bridging the gap between different specialties in the biomedical sciences field, Oncology has reviewed numerous insightful topics loved by many. Most of their research is on demand publications that are peer reviewed and ensure scientific research is shared as widely and efficiently as possible. Their ultimate goal is for humans to live without disease and this motivation has boosted the morale of the many scientists working in oncology and resume it.
The chief editor Blagosklonny earned his MD and Doctor of Philosophy at First Pavlov State Medical University. He has an excellent reputation for his specialization in cancer treatment and the aging process disciplines. His research has helped many and is admired by most in the medical sciences. In 2002 he was made an associate Professor at the New York Medical College and is now one of the members at the Roswell Park Cancer Institute. He has written many books on the aging hyper function field and is highly praised as one of the best oncologists in the world.
Andrei V. Gudkov is another editor at Oncotarget. The Russian born and educated scientist is well known for his insightful and excellent results in the field of oncology. He worked at the Cancer Research Centre in Moscow before emigrating to the U.S. Oncotarget has a huge team of highly trained researchers whose primary goal is a disease free world. They strive to publish well researched, knowledge filled and practical insights in the biomedical sciences and more information click here.
More Visit: https://twitter.com/oncotargetjrnl?lang=en